Theravance Biopharma
1 known investors
Theravance Biopharma develops FDA-approved pharmaceutical treatments, including YUPELRI for chronic obstructive pulmonary disease (COPD) maintenance treatment. The company focuses on delivering innovative medicines that address unmet medical needs.
Founders & leadership
RE
Rick E WinninghaminChief Executive Officer
RF
Rhonda F. FarnuminSenior Vice President, Commercial and Medical Affairs and Chief Business Officer
BA
Brett A. GrimaudinSenior Vice President, General Counsel and Secretary
SK
Stuart KnightSenior Vice President, IT&I and Chief Information Officer
AM
Aine MillerSenior Vice President, Development and Head of Ireland Office
SP
Stacy PryceinSenior Vice President and Chief Strategy Officer
AS
Aziz SawafChief Financial Officer and Senior Vice President of Operations Strategy
Investors · 1
Founder mafia
3 people who came through Theravance Biopharma went on to found or lead other companies.
Frequently asked questions
- What does Theravance Biopharma do?
- Theravance Biopharma develops FDA-approved pharmaceutical treatments, including YUPELRI for chronic obstructive pulmonary disease (COPD) maintenance treatment. The company focuses on delivering innovative medicines that address unmet medical needs.
- Who are Theravance Biopharma's investors?
- Theravance Biopharma's investors include HEALTHCARE ROYALTY PARTNERS.